잠시만 기다려 주세요. 로딩중입니다.

Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model

Archives of Pharmacal Research 2021년 44권 2호 p.230 ~ 240
양윤미, Wang Zhijun, Matsuda Michitaka, Seki Ekihiro,
소속 상세정보
양윤미 ( Yang Yoon-Mee ) - Cedars-Sinai Medical Center Department of Medicine
 ( Wang Zhijun ) - Cedars-Sinai Medical Center Department of Medicine
 ( Matsuda Michitaka ) - Cedars-Sinai Medical Center Department of Medicine
 ( Seki Ekihiro ) - Cedars-Sinai Medical Center Department of Medicine

Abstract


Hyaluronan (HA) as a glycosaminoglycan can bind to cell-surface receptors, such as TLR4, to regulate inflammation, tissue injury, repair, and fibrosis. 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis, is a drug used for the treatment of biliary spasms. Currently, therapeutic interventions are not available for non-alcoholic steatohepatitis (NASH). In this study, we investigated the effects of 4-MU on NASH using a choline-deficient amino acid (CDAA) diet model. CDAA diet-fed mice showed NASH characteristics, including hepatocyte injury, hepatic steatosis, inflammation, and fibrogenesis. 4-MU treatment significantly reduced hepatic lipid contents in CDAA diet-fed mice. 4-MU reversed CDAA diet-mediated inhibition of Ppara and induction of Srebf1 and Slc27a2. Analysis of serum ALT and AST levels revealed that 4-MU treatment protected against hepatocellular damage induced by CDAA diet feeding. TLR4 regulates low molecular weight-HA-induced chemokine expression in hepatocytes. In CDAA diet-fed, 4-MU-treated mice, the upregulated chemokine/cytokine expression, such as Cxcl1, Cxcl2, and Tnf was attenuated with the decrease of macrophage infiltration into the liver. Moreover, HA inhibition repressed CDAA diet-induced mRNA expression of fibrogenic genes, Notch1, and Hes1 in the liver. In conclusion, 4-MU treatment inhibited liver steatosis and steatohepatitis in a mouse model of NASH, implicating that 4-MU may have therapeutic potential for NASH.

키워드

CXCL1; Hyaluronic acid; Hymecromone; NASH; TLR4

원문 및 링크아웃 정보

등재저널 정보